Gavi, the Vaccine Alliance
Safety monitoring
Switzerland
This innovation refers to liquid vaccine formulations that are sufficiently heat stable to be kept in a CTC. CTC use of vaccines allows for single excursion of the vaccine into ambient temperatures not exceeding +40°C for a minimum of 3 days, just prior to administration.